Page 35 - Read Online

Watanabe. Vessel Plus 2020;4:4 I http://dx.doi.org/10.20517/2574-1209.2019.27 Page 9 of 10

46. Kim HW, Belin de Chantemèle EJ, Weintraub NL. Perivascular adipocytes in vascular disease. Arterioscler Thromb Vasc Biol
2019;39:2220-7.
47. Ahmadieh S, Kim HW, Weintraub NL. Potential role of perivascular adipose tissue in modulating atherosclerosis. Clin Sci (Lond)
2020;134:3-13.
48. Pandey GK, Vadivel S, Ranghavan S, Mohan V, Balasubramanyam M, et al. High molecular weight adiponectin reduces
glucolipotoxicity-induced inflammation and improves lipid metabolisim and insulin sensitivity via APPL1-AMPK-GLUT4 regulation in
3T3-L1 adipocytes. Atherosclerosis 2019;288:67-75.
49. Park M, Youn B, Zheng XL, Wu D, Xu A, et al. Globular adiponectin, acting via AdipoR1/APPL1. Protects H9c2 cells from hypoxia/
reoxygenation-induced apoptosis. PLoS One 2011;6:e19143.
50. Zhang Y, Zhao J, Li R, Lau WB, Yuan YX, et al. AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic
myocardial apoptosis through both AMPK-mediated and AMPK-independent signaling. Am J Physiol Endocrinol Metab 2015;309:E275-82.
51. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice.
Circulation 2002;106:2767-70.
52. Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, et al. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient
mice from atherosclerosis. J Biol Chem 2003;278:2461-8.
53. Sun L, Yang X, Li Q, Zeng P, Liu Y, et al. Activation of adiponectin receptor regulates proprotein convertase subtilisin/kexin type 9
expression and inhibits lesions in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2017;37:1290-300.
54. Ahmad A, Ali T, Kim MW, Khan A, Jo MH, et al. Adiponectin homolog novel osmotin protects obesity/diabetes-induced NAFLD by
upregulating AdipoRs/PPARα signaling in ob/ob and db/db transgenic mouse models. Metabolism 2019;90:31-43.
55. Kashyap H, Gupta S, Bist R. Impact of active antihyperglycemic components as herbal therapy for preventive health care management of
diabetes. Curr Mol Med 2019;19:12-9.
56. Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, et al. Antiinflammatory therapy with Canakinumab for atherosclerotic
disease. N Engl J Med 2017;377:1110-31.
57. Badshah H, Ali T, Kim MO. Osmotin attenuates LPS-induced neuroinflammation and memory impairments via the TLR4/NFκB signaling
pathway. Sci Rep 2016;6:24493.
58. Arsenescu V, Narasimhan ML, Halide T, Bressan RA, Barisione C, et al. Adiponectin and plant-derived mammalian adiponectin homolog
exert a protective effect in murine colitis. Dig Dis Sci 2011;56:2818-32.
59. Jian M, Kwan JS, Bunting M, Ng RC, Chan KH. Adiponectin suppresses amyloid-β oligomer (AβO)-induced inflammatory response of
microglia via AdipoR1-AMPK-NF-κB signaling pathway. J Neuroinflammation 2019;16:110.
60. Zhao Q, Liu Y, Tan L, Yan L, Zuo X. Adiponectin administration alleviates DSS-induced colonic inflammation in Caco-2 cells and mice.
Inflamm Res 2018;67:663-70.
61. Wanleenuwat P, Iwanowski O, Kozubski W. Alzheimer’s dementia: pathogenesis and impact of cardiovascular risk factors on cognitive
decline. Postgrad Med 2019;131:415-22.
62. Lather R, Sapronova A, Kotelevtsev Y. Atherosclerosis and Alzheimer-diseases with a common cause? Inflammation, oxysterols,
vasculature. BMC Geriatr 2014;14:36.
63. Fiolaki A, Tsamis KI, Milionis HJ, Kyritsis AP, Kosmidou M, et al. Atherosclerosis, biomarkers of atherosclerosis and Alzheimer’s
disease. Int J Neurosci 2014;124:1-11.
64. Xiang J. Carotid atherosclerosis promotes the progression of Alzheimer’s disease: a three-year prospective study. Exp Ther Med
2017;14:1321-6.
65. Abid NB, Yoon G, Kim MO. Molecular cloning and expression of osmotin in a Baculovirus-insect system: purified osmotic mitigates
amyloid-beta deposition in neural cells. Sci Rep 2017;7:8147.
66. Ali T, Yoon GH, Shah SA, Lee HY, Kim MO. Osmotin attenuates amyloid beta-induced memory impairment, tau phosphorylation and
neurodegeneration in the mouse hippocampus. Sci Rep 2015;5:11708.
67. Shah SA, Yoon GH, Chung SS, Abid MN, Kim TH, et al. Novel osmotin inhibits SREBP2 via the AdipoR1/AMPK/SIRT1 pathway to
improve Alzheimer’s disease neuropathological deficits. Mol Psychiatry 2017;22:407-16.
68. Yoon G, Shah SA, Ali T, Kim MO. The adiponectin homolog osmotin enhances neurite outgrowth and synaptic complexity via AdipoR1/
NgR1 signaling in Alzheimer’s disease. Mol Neurobiol 2018;55:6673-86.
69. Amin FU, Hoshiar AK, Do TD, Noh Y, Shah SA, et al. Osmotin-loaded magnetic nanoparticles with electromagnetic guidance for the
treatment of Alzheimer’s disease. Nanoscale 2017;9:10619-32.
70. Chan KH, Lam KS, Cheng OY, Kwan JS, Ho PW, et al. Adiponectin is protective against oxidative stress induced cytoxicity in amyloid-
beta neurotoxicity. PLos One 2012;7:e52354.
71. Song J, Choi SM, Whitcomb DJ, Kim BC. Adiponectin controls the apoptosis and the expression of tight junction proteins in brain
endothelial cells through AdipoR1 under beta amyloid toxicity. Cell Death Dis 2017;8:e3102.
72. Ng RC, Chan KH. Potential neuroprotective effects of adiponectin in Alzheimer’s disease. Int J Mol Sci 2017;18:592.
73. Weisz F, Piccinin S, Mango D, Nqomba RT, Mercuri NB, et al. The role of adiponectin receptors in the regulation of synaptic transmission
in the hippocampus. Synapse 2017;71:e21964.
74. Sima P, Vannucci L, Vetvicka V. Immunity in cancer and atherosclerosis. Ann Transl Med 2019;7:204.
75. Raposeiras Roubin S, Cordero A. The two-way relationship between cancer atherosclerosis. Rev Esp Cardiol (Engl Ed) 2019;72:487-94.
76. Jiang J, Fan Y, Zhang W, Shen Y, Liu T, et al. Adiponectin suppresses human pancreatic cancer growth through attenuating the β-catenin
signaling pathway. Int J Biol Sci 2019;15:253-64.